COPD is characterised by irreversible airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response. This inflammation can be amplified with flare-ups that are commonly seen in COPD patients. Pulmonary rehabilitation is one of the most effective methods of managing chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation has been seen to induce improvements in functional capacity and quality. In healthy individuals, exercise has been shown to induce an anti-inflammatory response when performed regularly. However, the effects of exercise on inflammation in COPD are unclear. Our initial CIMPRES-COPD study has looked into the effects of short-term exercise, as part of pulmonary rehabilitation, on inflammation. However, this trial will examine the inflammatory response in COPD patients who are most active following pulmonary rehabilitation against those who are least active. This study will split participants into 2 groups according to physical activity level following pulmonary rehabilitation. We will recruit 40 COPD patients who provided a sample in the initial CIMPRES-COPD study to explore inflammatory responses in those who are most active and least active. By better understanding the mechanisms of how long-term physical activity levels affects inflammation in COPD, we could design better interventions to increase physical activity levels following pulmonary rehabilitation.
Study Type
OBSERVATIONAL
Enrollment
18
COPD patients will wear an accelerometer and complete questionnaires related to daily physical activity levels for 7 days before returning for a clinic visit.
Lindum Medical Practice
Lincoln, Lincolnshire, United Kingdom
Nettleham Medical Practice
Lincoln, Lincolnshire, United Kingdom
Birchwood Medical Practice
Lincoln, Lincolnshire, United Kingdom
Cytokines
Changes in concentration of inflammatory cytokines in the plasma of all participants using ELISA's (mg/L)
Time frame: May 2018 - August 2018
Leukocyte count
Changes in total and differential leukocyte count in all participants (10\^9.L-1)
Time frame: May 2018 - August 2018
Cell function
Changes in function of the following cells: myeloperoxidase, neutrophil elastase, MMP-8, MMP-9, TNF-a in the plasma of all participants using ELISA's (mg/L)
Time frame: May 2018 - August 2018
Cell sensitivity to corticosteroids
Changes in cell sensitivity to corticosteroids and forskolin in all participants (expressed as fold increase from not treated samples)
Time frame: May 2018 - August 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.